Breaze L Kid Tablet (10 Tab)

Medicine Information

About Breaze L Kid Tablet:

Breaze L Kid Tablet is a combination medicine, indicated for relieving symptoms of allergic rhinitis in children.

Each uncoated dispersible Breaze L Kid Tablet contains Levocetirizine Hydrochloride 2.5 mg and Montelukast Sodium equivalent to Montelukast 4 mg.

Montelukast is a selective leukotriene receptor antagonist. Leukotriene type-1 receptor is located on the respiratory airway and on pro-inflammatory cells. It has been correlated with the pathophysiology of asthma and allergic rhinitis. By inhibiting the leukotriene type-1 receptor, Montelukast helps reduce inflammation in the airways and relieve allergic symptoms.

Levocetirizine is an antiallergic medication that selectively inhibits histamine H1 receptors. This action prevents the negative symptoms associated with histamine release and provides relief from allergic reactions.

Use of Breaze L Kid Tablet:

Breaze L Kid Tablet is a combination of Levocetirizine and Montelukast, which is prescribed to relieve symptoms associated with allergic rhinitis (seasonal and perennial) in children.

Usage Direction of Breaze L Kid Tablet:

• Breaze L Kid Tablet is intended for oral use only, in a dose and direction as prescribed by the physician.
• Disperse the Breaze L Kid Tablet in a teaspoonful of boiled & cooled water immediately before administration.
• Do not skip or stop the medicine without the physician’s advice.
• Do not consume more than the prescribed quantity.

Precaution & Related information of Breaze L Kid Tablet:

• If hypersensitive or allergic to Breaze L Kid Tablet, inform the physician immediately.
• If found any other complications, inform the physician immediately.
• The Physician should be well informed when concomitant consumption of this tablet with any other medicines or supplements.
• Keep out of reach of children.

Storage condition of Breaze L Kid Tablet:

• Store protect from light & moisture, at a temperature not exceeding 30°C.